The end of the road for CETP inhibitors after torcetrapib?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference71 articles.
1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005
2. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study;Gordon;Am J Med,1977
3. Effects of torcetrapib in patients at high risk for coronary events;Barter;N Engl J Med,2007
4. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia;Kastelein;N Engl J Med,2007
5. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial;Bots;Lancet,2007
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP);Pharmaceutics;2019-07-15
2. From lipid locus to drug target through human genomics;Cardiovascular Research;2018-05-23
3. Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport;PLOS ONE;2017-03-09
4. Unending saga of fighting cholesterol: Evacetrapib is another fallen warrior;Bratislava Medical Journal;2017
5. Discontinued cardiovascular drugs in 2015;Expert Opinion on Investigational Drugs;2016-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3